Melissa Chrispijn

The long‐term outcome of patients with polycystic liver disease treated with lanreotide

Melissa Chrispijn, F. Nevens, Tom J.G. Gevers et al. · Alimentary Pharmacology & Therapeutics · 2011 · 96 citations · Full text

Medicine, Pharmacotherapy, Radiology +16

Whole-exome sequencing reveals <i>LRP5</i> mutations and canonical Wnt signaling associated with hepatic cystogenesis

Wybrich R Cnossen, René H. M. te Morsche, Alexander Hoischen et al. · Proceedings of the National Academy of Sciences · 2014 · 88 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial

Melissa Chrispijn, Tom J.G. Gevers, Jeroen Hol et al. · Journal of Hepatology · 2013 · 80 citations

Medicine, Pharmacology, Pharmacotherapy +10

Complications arising in simple and polycystic liver cysts

Christian Macutkiewicz, Ricci Plastow, Melissa Chrispijn et al. · World Journal of Hepatology · 2012 · 61 citations · Full text

Medicine, Pathology, Radiology +17

Measuring personal recovery in people with bipolar disorder and exploring its relationship with well‐being and social role participation

Jannis T. Kraiss, Peter M. ten Klooster, Melissa Chrispijn et al. · Clinical Psychology & Psychotherapy · 2019 · 26 citations · Full text

Social Sciences, Psychiatry, Psychology +15